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ABSTRACT
Objective: This prospective randomized study assessed the effect of
waiting time (WT) on health outcomes in Finnish patients admitted to
hospital for primary total hip replacement (THR).
Methods: A total of 395 consecutive patients with a need for a primary
THR because of osteoarthritis and who were placed on the waiting
list between August 2002 and November 2003. After placement on
the waiting list, the patients were randomly assigned to a short WT
(3 months) group (n = 174) or a nonﬁxed WT group (n = 221). The
patients completed self-administered questionnaires at the time of
placing on the waiting list and at hospital admission. Health-related
quality of life was measured by the generic 15D instrument. Hip pain
and function were measured by the patient self-report Harris hip score
(HHS).
Results: Of the 395 patients, 312 (79%) completed the follow-up (140
patients with short and 172 with nonﬁxed WT). At admission, the mean
15D scores for patients with short and nonﬁxed WT were 0.784 and
0.783, respectively. In the intention-to-treatment analysis, the difference
between the groups (D0.001, 95% conﬁdence interval [CI]: –0.019 to
0.021) was not statistically signiﬁcant or clinically important. The mean
self-report HHS in patients with short WT was 43.5, and among those
with nonﬁxed WT was 41.9. The difference (D1.6, 95% CI: –1.77 to 4.87)
was not statistically signiﬁcant.
Conclusions: Both generic and disease-speciﬁc measures revealed that
longer WTs did not result in poorer health status at admission.
Keywords: access to health care, effectiveness, health-related quality of
life, osteoarthritis, randomized clinical trial.
Introduction
Equal access to treatment is a key performance indicator of
medical care in Finland. According to the Organization for Eco-
nomic Co-operation and Development (OECD), comparative
analysis of 20 OECD countries reported at the beginning of the
21st century that waiting times (WTs) are a serious health policy
concern. When comparing common surgical procedures, Finland
and the United Kingdom followed by Denmark, Norway, Aus-
tralia, and Canada were the countries with the longest WTs [1].
Major joint replacement is an example of surgery with a high
volume of demand and relatively long waiting periods for
patients. Interest in examining the relationship between health
status and time spent waiting for surgery has increased since the
beginning of 2000. The majority of studies have found no rela-
tionship between health-related quality of life (HRQoL) and
time spent on the elective waiting list [2–4]. Nevertheless, some
disease-speciﬁc instruments have indicated signiﬁcant deteriora-
tion in physical function and increase in pain while waiting [5,6].
A prospective Canadian study concluded that clinically impor-
tant losses in HRQoL and mobility occur in total hip arthro-
plasty patients waiting more than 6 months [7]. Further, some
studies [8,9] have shown that patients in a later phase of disease
do not achieve the same level of outcome as those with better
preoperative function, a justiﬁed reason for paying attention to
the changes in health status while waiting.
Inconsistency in empirical results is partly explicable because
of differences in study settings, measures (disease speciﬁc or
generic), sample size, and follow-up period. The absence of con-
trolled trials that randomly assign patients to speciﬁc WT pre-
vents the establishing of a relationship between the length of wait
and the health outcome [7].
The aim of this prospective, multicenter, randomized con-
trolled trial was to assess the relationship between HRQoL, pain,
physical function, and WT in total hip replacement (THR)
patients with short WT and those where the WT was not ﬁxed in
advance, but the patient was following the hospital’s routine
practice.
Methods
Study Population
Patients were enrolled into this study in three Finnish hospitals
(Helsinki University Central Hospital [HUCH] Surgical Hospi-
tal, Helsinki; HUCH Jorvi Hospital, Espoo; and Coxa Hospital
for Joint Replacement, Tampere). Two hospitals were university
hospitals providing services for municipalities in the capital area.
The third hospital is specialized in endoprosthetic surgery and
provides services for municipalities, local and central hospitals,
as well as for patients paying the costs themselves.
The inclusion criteria were: a need for a primary unilateral or
bilateral THR because of osteoarthritis (OA) as evaluated by the
orthopedic surgeon, aged 16 years or older, patient was placed on
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the waiting list in a research hospital, and the patient was willing
and mentally able to participate in the study. Patients with rheu-
matoid arthritis, fractures, hemophilia, and deformity were
excluded. The study had ethical approval from the HUCH
Surgery Ethics Committee (registration number 134/E6/02).
Randomization
Consecutive patients were recruited into the study through
regular contact with the orthopedic surgeons and nursing staff
between August 2002 and November 2003. The last patient was
admitted to hospital in May 2005. Patients came for an out-
patient orthopedic surgeon assessment with a referral from a
health center, local hospital, or a private physician.
After being placed on the waiting list according to clinical
criteria, those meeting the inclusion criteria were asked to take
part in the study. Those willing to participate were randomly
assigned to either short (maximum 3 months) or nonﬁxed WT
(patient received surgery according to the hospital’s routine pro-
cedure from the date he or she was added to the waiting list to the
date of surgery).
The patients were recruited into the study in four (at one
hospital in three recruitment periods) recruitment periods of 3
months (Table 1). The patients in the short WT group were
operated within 2 weeks after each recruitment period, and they
waited maximum 3 months for the surgery. This arrangement
was needed because operating rooms for the surgeries of the
short WT patients had to be booked in advance before recruit-
ments. All patients placed on the waiting list because of OA of
the hip joint had a chance of getting recruitment into the study
(either into the short or nonﬁxed WT group). Hospitals’ capacity
to operate patients in maximum 3 months was limited, and thus,
the patients were allocated in unequal numbers to either short
(n = 174) or nonﬁxed (n = 221) WT.
The tasks of generating the random sequence and implement-
ing the assignment were separated between researchers and clini-
cal staff. The random allocation sequence was drawn up using a
computer-generated randomization list. In each hospital, after a
patient was placed on the waiting list, was informed of the study,
and had provided a signed consent, the patient’s named nurse
assigned participants to their groups using consecutively num-
bered, sealed, opaque envelopes. A separate randomization pro-
cedure was performed within each hospital.
Surgeons were unaware of the assigned intervention. For
ethical reasons, double-blinding was not possible.
Measures
The primary outcome measure was patient’s HRQoL measured
by the 15D. The 15D is a generic and standardized HRQoL
instrument consisting of 15 dimensions: moving, seeing, hearing,
breathing, sleeping, eating, speech, elimination, usual activities,
mental function, discomfort and symptoms, depression, distress,
vitality, and sexual activity. For each dimension, the respondent
must choose one of the ﬁve levels that best describes his/her state
of health at the moment (best level = 1; worst level = 5) [10,11].
The single index (15D score) on a 0–1 scale, representing the
overall HRQoL, is calculated from the health state descriptive
system by using a set of population-based preference or utility
weights. Such a weight for each level of each dimension is
obtained by multiplying the level value by the importance weight
of the dimension at that level. The level values on a 0–1 scale,
reﬂecting the goodness of the levels relative to no problems on
the dimension (= 1) and to being dead (= 0), and the importance
weights summing up to unity, have been elicited from represen-
tative population samples. The 15D has been/is being utilized
among different patient groups (e.g., patients undergoing hip or
knee arthroplasty) to assess outcomes from health-care interven-
tions [12]. In most of the important properties (e.g., responsive-
ness, sensitivity, reliability, validity), the 15D compares favorably
with other instruments of the same kind, such as EQ-5D, HUI3,
SF-6D, and AQoL [11,13–15].
The patient self-report Harris hip score (HHS) disease-
speciﬁc test was used as a secondary outcome measure to
measure hip pain and function [16]. The self-report HHS consists
of pain (0–44 points) and function (0–46 points) subdivided into
activities of daily living (ADL, 0–13 points) and gait (0–33
points). The total score ranges from 0 to 90 points, with a high
score representing the best health state. Deformity and motion
were excluded because the items could not be measured in a
patient self-administered questionnaire. The performance of a
self-reported HHS is comparable to that of a surgeon-assessed
HHS and has shown to be less burdensome to patients than
physician-administered HHS [16].
The patients completed a self-administered questionnaire at
two points in time: 1) when placed on the waiting list (baseline);
and 2) at hospital admission. The questionnaires were distributed
to patients at hospital and returned by mail to the research
institute. Common guidelines for administering the question-
naires were provided in each hospital, and the protocol speciﬁed
that a named nurse distributed the questionnaire to the patient.
Statistics
The sample size estimate was based on the primary outcome
variable (15D). A subgroup of 177 patients would provide the
80% power (two-tailed a-error 5%) to detect clinically impor-
tant differences (D0.03) in the 15D score between the groups
[17].
Primary analyses were based on the intention-to-treat (ITT)
principle, and comparisons were between the randomized
groups. Comparative analyses of baseline sociodemographic and
clinical characteristics between patients who completed the ques-
tionnaires (baseline and admission) and those lost to follow-up
were carried out using either the independent sample t test or
the chi-square test depending on the level of measurement. In
a further per-protocol analysis, we excluded those short WT
patients who were admitted beyond short WT (WT > 3 months).
In addition, linear regression analysis was used as a supplemen-
Table 1 Recruitment periods
Hospital 1* Hospitals 2 and 3
Recruitment period I Recruitment I Recruitment
December 1, 2002 to
February 28, 2003
September 2 to November
30, 2002
II Recruitment II Recruitment
February 3 to
May 30, 2003
December 1, 2002 to
February 28, 2003
III Recruitment III Recruitment
August 18 to
October 31, 2003
March 3 to May 30, 2003
IV Recruitment
August 18 to October
31, 2003
Short WT patients
were operated
I Recruitment I Recruitment
2003: Weeks 10, 11 2002: Weeks 49, 50
II Recruitment II Recruitment
2003: Weeks 23, 24 2003: Weeks 10, 11
III Recruitment III Recruitment
2003: Weeks 45, 46 2003: Weeks 23, 24
IV Recruitment
2003: Weeks 45, 46
*Because of hospital’s capacity, only three recruitment periods were needed.
WT, waiting time.
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tary analysis to determine the relationship between WT and
HRQoL at admission with WT as an independent variable.
The group differences in the 15D score, pain, ADL, and gait
were tested by the independent sample t test. Conﬁdence inter-
vals (CIs) of 95% were calculated for mean differences in the
outcomes at admission. All differences are presented as short WT
minus nonﬁxed WT. Two-sided P-values were calculated in all
analyses with the minimum signiﬁcant level set at 5%. Data
analyses were performed using SPSS for Windows, version 12.0.1
(SPSS Inc., Chicago, IL, USA).
Missing values for the 15D dimensions were predicted by
regression models with the responses on the other dimensions,
age, and gender as explanatory variables [10]. A missing value
was substituted if a minimum 80% of responses on the dimen-
sions were present.
Results
Participants
Of the 503 eligible patients, 108 (21.5%) patients (70 females)
with a mean age of 70 (SD 10.4) years were excluded after being
informed on the study (Fig. 1). Thus, 395 patients were ran-
domly allocated into short WT (n = 174) or nonﬁxed WT
(n = 221). A total of 373 patients completed the baseline ques-
tionnaire. Some 61 patients were lost to follow-up between the
baseline and admission measurements and were not included in
the ﬁnal analyses. Both the baseline and admission question-
naires were ﬁlled in by 312 patients, of which 140 were in the
short WT and 172 in the nonﬁxed WT group.
Baseline Characteristics
The baseline characteristics of the patients are presented in
Table 2. The patients with comorbidity totaled 210, while
patients without comorbidity totaled 102. The most common
coexisting disease was cardiovascular disease, followed by high
cholesterol, diabetes mellitus, and endocrinological problems.
Both randomized groups were comparable in baseline demo-
graphic and clinical characteristics. The mean (SD) baseline 15D
score of the 312 patients was 0.783 (0.087). The majority of the
patients (n = 271; 88.6%) experienced moderate to severe pain,
and six (2.0%) patients were totally disabled. A total of 158
(51.3%) patients used walking support, and 294 (95.5%)
patients had difﬁculties with climbing stairs.
Of the patients who completed the questionnaires, 113 (36%)
waited 0–3 months and 78 (25%) waited more than 3 months
but less than 6 months. A total of 121 (39%) patients waited
more than 6 months, of which 26 patients waited a year or more.
A comparison between patients who completed the question-
naires (baseline and admission) and those who were lost to
follow-up showed that those who were lost to follow-up were
older than patients who completed the questionnaires (t = 2.1,
P = 0.034), were more often living alone (X2 = 11.0, P = 0.001),
and scored lower for gait (t = 2.5, P = 0.014).
Outcomes
In patients with short WT, the mean (SD) 15D score at admission
was 0.784 (0.089), and in nonﬁxed WT patients 0.783 (0.090)
(Table 3). The mean difference (D0.001) between the groups was
not statistically signiﬁcant or clinically important.
Bigible participants (n = 503)
Randomly allocated (n = 395)
Allocated to short WT (n = 174)
Baseline measurement (n = 164)
Allocated to nonfixed WT (n = 221)
Baseline measurement (n = 209)
Lost to follow-up (n = 24) Lost to follow-up (n = 37)
Surgery was canceled (n = 1)
Exited the queue (n = 3)
Did not return the form (n = 20)
Surgery was canceled (n = 3)
Exited the queue (n = 7)
Did not return the form (n = 20)
Operated elsewhere (n = 5)
Died while waiting (n = 2)
Measurement at admission (n = 140)
Analyzed (n = 140) Analyzed (n = 172)
Measurement at admission (n = 172)
Admission within short WT (n = 87)
Admission beyond short WT (n = 53)
Excluded (n = 108)
Refused to participate (n = 102)
Other reasons (n = 6)
Figure 1 Flow of participants.
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A per-protocol analysis was performed as a supplementary
analysis. In the short WT group, those compliant with allocated
WT (n = 87) and all patients in the nonﬁxed WT group (n = 172)
were included in the analysis. Similar results were obtained in a
per-protocol analysis, and WT did not show a signiﬁcant effect
on the 15D score at admission (D–0.003).
A linear regression analysis was performed to estimate the
relationship between WT and 15D score at admission. WT did
not show a signiﬁcant effect on the 15D score at admission
(b = –0.0002, P = 0.867, 95% CI: –0.002 to 0.002, data not
shown).
The patient self-report HHS, pain, ADL, and gait were used
as secondary outcome measures. At admission, the mean HHS
scores in the short and nonﬁxed WT groups were 43.5 (SD 15.1;
range 6–90) and 41.9 (SD 14.5; range 2–80), respectively. In
patients with short WT, the mean (SD) pain score was 17.8 (8.0),
and in patients with nonﬁxed WT, 17.1 (8.6). The pain score of
HHS at admission ranged from 0 (totally disabled, pain at rest,
n = 13, 4.3%) to 44 (no pain, n = 5, 1.6%). A total of 22 patients
(7.2%) reported mild pain after unusual activity, 157 (51.5%)
reported moderate pain, and 101 (33.1%) reported marked or
severe pain.
With regard to function, the great majority of patients
reported limitations in ADL and gait. At admission, 128 patients
(41.7%) did not need any support and the rest 178 (58.3%)
patients used cane, crutch, and walker, or were totally unable to
walk.
The results of the ITT analysis showed that there were no
statistically signiﬁcant differences in the self-report HHS total
score and the levels of pain, ADL, and gait between the groups at
admission (Table 3). In the per-protocol analysis, no statistical
differences between the groups were found (Table 4).
Conclusion
The main ﬁndings of our study are: 1) at admission, there were
no statistically signiﬁcant and clinically important differences in
HRQoL, pain, and function between the groups with different
Table 2 Demographic and clinical characteristics of patients (intention-to-treat analysis)
Characteristics at baseline
Short WT
(n = 140)
Nonﬁxed WT
(n = 172)
Lost to follow-up
(n = 61) P-value*
Age (years) (mean SD) 66 9.7 65 9.8 68 10.4 0.034
Females [n, (%)] 82 (58.6) 86 (50.0) 38 (62.3) 0.225
Living alone [n, (%)] 43 (30.7) 39 (22.7) 29 (47.5) 0.001
Home municipality [n, (%)] 0.326
Rural area 23 (16.4) 36 (21.3) 10 (16.4)
Capital area 76 (54.3) 86 (50.3) 38 (62.3)
Other urban area 41 (29.3) 49 (28.7) 13 (21.3)
Professional examination, yes [n, (%)] 52 (37.1) 67 (39.0) 22 (36.1) 0.760
Employment status [n, (%)] 0.357
Employed 27 (19.3) 44 (25.6) 9 (14.8)
Retired 104 (74.3) 120 (69.8) 49 (80.3)
Other 9 (6.4) 8 (4.7) 3 (4.9)
Body mass index† (mean SD), kg/m2 28.3 3.9 28.4 4.6 27.4 5.2 0.141
Comorbidity, yes [n, (%)] 96 (68.6) 114 (66.3) 44 (72.1) 0.460
Waiting time, days [Md, range] 81 (9–541) 194 (7–756)
Months waiting for surgery [n, (%)]
0–3 87 (62.1) 26 (15.1)
>3–6 30 (21.4) 48 (27.9)
>6 23 (16.4) 98 (57.0)
15D score‡ (mean SD) 0.780 (0.086) 0.785 (0.088) 0.760 (0.077) 0.056
Self-report HHS§ 43.4 (13.7) 44.2 (14.0) 40.2 (12.5) 0.063
Pain|| 16.6 (7.5) 17.5 (6.8) 16.3 (7.6) 0.417
ADL¶ 8.2 (1.7) 8.1 (2.0) 7.9 (1.7) 0.426
Gait# 18.6 (7.6) 18.8 (7.6) 16.3 (6.6) 0.014
*Difference between those who completed the questionnaires (baseline and admission) and those lost to follow-up.
†n = 171 in the group of nonﬁxed WT; n = 59 among those lost to follow-up because of missing values.
‡The scale is 0–1, worst to best.
§Total score. Data are mean (SD) scores on the scale 0–90, worst to best.
||Data are mean (SD) scores on the scale 0–44 (0 = disabled, 10 =marked pain, 20 =moderate, 30 =mild, 40 = slight, 44 = no pain).
¶Activities of daily living. Data are mean (SD) scores on the scale 0–13, worst to best (stairs 0–4, shoes and socks 0–4, sitting 0–5).
#Data are mean (SD) scores on the scale 0–33 worst to best (limp 0–11, the support required 0–11, distance walked 0–11).
HHS, Harris hip score;WT, waiting time.
Table 3 Outcome measures at admission (intention-to-treat analysis)
Outcome measure
Short WT
(n = 137–140)*
Nonﬁxed WT
(n = 168–172)* Mean difference (95% CI) P-value
15D score† 0.784 (0.089) 0.783 (0.090) 0.001 (-0.019 to 0.021) 0.931
Self-report HHS 43.5 (15.1) 41.9 (14.5) 1.6 (-1.768 to 4.869) 0.359
Pain 17.9 (8.0) 17.1 (8.6) 0.7 (-1.270 to 2.511) 0.519
ADL 8.0 (2.1) 7.6 (2.2) 0.4 (-0.116 to 0.852) 0.136
Gait 18.3 (7.4) 17.5 (7.0) 0.8 (-0.792 to 2.445) 0.316
*Number of observations varies because of missing values.
†Mean (SD) 15D score.The scale is 0–1, worst to best.
ADL, activities of daily living; CI, conﬁdence interval; HHS, Harris hip score; WT, waiting time.
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average WT; and 2) both disease-speciﬁc and generic measures
supported the conclusion that WTs were unrelated to the health
status at admission.
Our ﬁndings corroborate previous studies that have found no
signiﬁcant difference in HRQoL between patients with short and
longer waits [3,4]. Those studies were, however, not based on a
randomized design, and thus in those studies, patients with more
severe symptoms may have had surgery more quickly than those
with less severe symptoms and longer WT.
In the test group, WT was limited to 3 months reﬂecting the
preparatory work of the national working group on access to
care and waiting list management [18]. According to the working
group, medically justiﬁed treatment must be provided within 3
months, or at the very latest, 6 months. In this respect, the ﬁnding
that there was no difference in health status at admission between
patients with short WT (median WT 3 months) and those with
nonﬁxed WT (median 6 months) may support guidelines for
medically justiﬁed treatment within 6 months or even beyond
instead of 3 months. Nevertheless, although longer WTs did not
result in poorer health status at admission, the patients suffered
from restrictions in health such as moderate to severe pain and
limitations in function at both measurement points.
One of the strengths of this multicenter study was that
patients awaiting primary THR were prospectively followed
from the time the patient was placed on the waiting list to the
time of admission, with WTs calculated exactly. Further, patients
were randomly assigned to either short or nonﬁxed WT, provid-
ing evidence of the effect of WT on preoperative health status.
The ﬁndings were also based on the simultaneous use of both a
generic and disease-speciﬁc instrument as outcome measures,
allowing a more global assessment of THR than if the measures
were utilized separately [19].
The sample was drawn from three large hospitals across two
hospital districts, and the sex and age structure of the patients in
this study were similar to those of Finnish THR patients [20].
Further, the median WT for the patients with nonﬁxed WT (194
days) was longer than was the median WT for Finnish patients
awaiting primary prosthetic replacement of hip joint in 2003
(155 days), although the WT in this study was comparable to
national WTs when taking into account the signiﬁcant regional
differences [20]. For example, in 2002, the shortest median WT
for the primary hip replacement was 84 days, and the longest 327
days when comparing the 20 hospital districts [21]. In relation to
some countries, the median WT in patients with nonﬁxed WT
was long. For example, in Australia, the median inpatient WT of
the THR patient admitted in 2000 was 98 days, in Canada
(British Columbia) 112 days, and in Norway 99 days [1].
Most patients (81%) were residing in the urban area, which
may limit our study’s generalizability to rural populations. A
previous study has shown that urban THR patients may differ
from rural patients with respect to pain threshold and percep-
tions on function [22].
To avoid selection bias among the patients, consecutive
patients placed on the waiting list were recruited into the study.
Nevertheless, a total of 108 eligible subjects were excluded from
the trial. The majority of those excluded were not willing to
participate in the study and they did not give consent. That those
excluded (mean age of 70 years) were older than completing
participants (mean age of 65 years) may have resulted in more
positive outcomes if only those with relatively mild disease at the
time of listing for surgery were randomized. Completing partici-
pants experienced, however, substantially poorer HRQoL com-
pared to that of an age-matched general Finnish population
sample [23] and the majority of patients experienced moderate to
severe pain and limitations in function while waiting.
A selection bias may have also resulted if the research hospi-
tals were not representative of the Finnish hospitals as a whole.
The sample was, however, drawn from three large hospitals
across two hospital districts, and the sex and age structure of the
patients who completed the trial were representative of Finnish
THR patients [21].
A limitation of the study was that 53 patients in the short WT
group waited longer than 3 months before being operated on.
This may have resulted in an underestimation of the WT effect.
The primary analysis was, however, based on the ITT principle to
address the question of clinical effectiveness and treatment
policy, and to avoid the bias associated with a nonrandom loss
of participants. The additional analyses—a per-protocol analysis
where the short WT patients who were admitted beyond short
WT were excluded from the analysis and a regression model with
WT as an independent variable—supported the main ﬁnding and
did not show a statistically signiﬁcant or clinically important
difference in HRQoL between the randomized groups. Nurse’s
feedback on the study protocol revealed explanations of why 53
patients in the short WT group did not receive the allocated
intervention in time. Some patients wanted to postpone surgery
that inconveniently arrived too soon, some were not clinically
ready for surgery, randomization had not been clearly noticed in
the hospital, or there was no capacity to carry out surgery within
3 months. These explanations relate to current clinical practice in
Finnish health care. The nationwide principles of access to health
care within a reasonable period came into force in March 2005.
Although “maximum WT guarantee” has improved access to
treatment, some areas have reported problems in access to care
because of the hospitals’ limited surgical capacity or patients’
unwillingness to care within the time speciﬁed [24].
For ethical reasons, double-blinding was not possible and the
patients were aware of the length of wait. Thus, the knowledge
that they were accessing treatment within 3 months may have
inﬂuenced the patients’ self-evaluation of their HRQoL. For
example, Achat et al. [25] have found that optimism in older
patients is associated with higher scores in health status.
Patients’ subjective perceptions as measured by validated and
standardized generic health measurement instruments are of
Table 4 Outcome measures at admission (per-protocol analysis)
Outcome measure Short WT (n = 87)* Nonﬁxed WT (n = 168–172)† Mean difference (95% CI) P-value
15D score 0.780 (0.089) 0.783 (0.090) -0.003 (-0.026 to 0.020) 0.802
Self-report HHS 43.5 (16.5) 41.9 (14.5) 1.3 (-2.621 to 5.279) 0.508
Pain 17.5 (8.3) 17.1 (8.6) 0.4 (-1.863 to 2.613) 0.742
ADL 7.9 (2.3) 7.6 (2.2) 0.3 (-0.271 to 0.880) 0.298
Gait 18.3 (7.9) 17.5 (7.0) 0.8 (-1.095 to 2.707) 0.405
*The 53 short WT patients admitted beyond short WT were excluded.
†Number of observations varies because of missing values.
ADL, activities of daily living; CI, conﬁdence interval; HHS, Harris hip score;WT, waiting time.
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clinical relevance when planning and developing recommenda-
tions for priority setting in clinical decision-making. In this study,
longer WT did not result in poorer HRQoL at admission, but
patients seemed to be tolerant of moderate waiting. We even
found that some patients wanted to postpone surgery. Neverthe-
less, OA is a slowly progressive disorder, and thus it is essential
to identify the patients in the poorest health. The ﬁndings of this
study have health political relevance when searching for more
sustainable ways of allocating WTs, and developing recommen-
dations and criteria for assessing health-care needs for elective
treatment. Continued investigation of long-term effects and the
stability of the effects of WT, as well as the effects of waiting on
the demand for social and health services and medication, are
becoming increasingly necessary and important.
Source of ﬁnancial support: Academy of Finland, HUCH, Jorvi Hospital;
Coxa Hospital for Joint Replacement, Medical Research Fund of Tampere
University Hospital; HUCH, Surgical Hospital, and ORTON Orthopaedic
Hospital.
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